DNA immunization confers protective immunity on mice challenged intravaginally with herpes simplex virus type 2

Keyphrases

• Protective Immunity 100%
• Herpes Simplex Virus 2 (HSV-2) 100%
• Glycoprotein D 100%
• Herpes Simplex Virus Type 1 (HSV-1) 100%
• DNA Immunization 100%
• Nucleic Acid Vaccine 100%
• Cellular Immune Response 50%
• Antibody Response 50%
• Immunization 50%
• Immunogenicity 50%
• Genital 50%
• Genital Tract 50%
• Virus Replication 50%
• IgA Antibody 50%
• Virus Challenge 50%
• Cell-mediated Immune Response 50%
• Serum IgE 50%
• Intramuscular Injection 50%
• Antigen-specific 50%
• Protective Efficacy 50%
• Gene Promoter 50%
• Immediate-early Gene 50%
• Splenocytes 50%
• Vaginal Secretions 50%

Immunology and Microbiology

• Adoptive Immunity 100%
• Herpes Simplex Virus 2 100%
• Glycoprotein 100%
• Human Alphaherpesvirus 1 100%
• DNA Vaccination 100%
• DNA Immunization 100%
• Antibody Response 50%
• Immunogenicity 50%
• Promoter Region 50%
• Antigen Specificity 50%
• Viral Replication 50%
• Immunoglobulin A Antibody 50%
• Immediate Early Gene 50%
• Vaginal Secretion 50%
• Lymphocyte 50%

Biochemistry, Genetics and Molecular Biology

• Nucleic Acid 100%
• Glycoprotein 100%
• Cellular Immunity 100%
• Human Alphaherpesvirus 1 100%
• Herpes Simplex Virus 2 100%
• Virus Replication 50%
• Secretion (Process) 50%
• Immunoglobulin A 50%
• Immunogenicity 50%
• Gene Promoter 50%
• Immediate Early Gene 50%
• Antibody Response 50%
• Antigen Specificity 50%
• Lymphocyte 50%